Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium

International Journal of Cancer

Volumn 138, Issue 1, 2016, Pages 55-64

  Drahos, Jennifer ^a   Xiao, Qian ^a   Risch, Harvey A ^b   Freedman, Neal D ^a   Abnet, Christian C ^a   Anderson, Lesley A ^c   Bernstein, Leslie ^d   Brown, Linda ^e   Chow, Wong Ho ^f   Gammon, Marilie D ^g   Kamangar, Farin ^h   Liao, Linda M ^a   Murray, Liam J ^c   Ward, Mary H ^a   Ye, Weimin ⁱ   Wu, Anna H ^j   Vaughan, Thomas L ^k   Whiteman, David C ^l   Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e RTI INTERNATIONAL   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g University of North Carolina at Chapel Hill   (United States)

^h MORGAN STATE UNIVERSITY   (United States)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k USA   (United States)

^l QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

more..

Author keywords

age of onset; case control studies; esophageal cancer; obesity; risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; OBESITY; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ADENOCARCINOMA; BARRETT ESOPHAGUS; COMPLICATION; DRINKING BEHAVIOR; ESOPHAGEAL NEOPLASMS; FEMALE; MALE; MIDDLE AGED; ODDS RATIO; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SMOKING;

EID: 84944274262     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29688     Document Type: Article

References (51)

1. Drahos J, Wu M, Anderson WF, et al., Regional variations in esophageal cancer rates by census region in the United States, 1999-2008. PLoS One 2013; 8: E67913.
2. Thrift AP, Whiteman DC., The incidence of esophageal adenocarcinoma continues to rise: Analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-62.
3. Brown LM, Devesa SS, Chow WH., Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-7.
4. Cook MB, Chow WH, Devesa SS., Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-9.
5. Devesa SS, Blot WJ, Fraumeni JF, Jr., Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
6. Dubecz A, Gall I, Solymosi N, et al., Temporal trends in long-term survival and cure rates in esophageal cancer: A SEER database analysis. J Thorac Oncol 2012; 7: 443-7.
7. Hashemi N, Loren D, DiMarino AJ, et al., Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci 2009; 54: 1708-12.
8. Portale G, Peters JH, Hsieh CC, et al., Esophageal adenocarcinoma in patients
9. Wu IC, Zhao Y, Zhai R, et al., Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. Neoplasia 2011; 13: 386.
10. Chow WH, Finkle WD, McLaughlin JK, et al., The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474-7.
11. Wu AH, Tseng CC, Bernstein L., Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003; 98: 940-8.
12. Pohl H, Wrobel K, Bojarski C, et al., Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol 2013; 108: 200-7.
13. Lagergren J, Bergstrom R, Lindgren A, et al., Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
14. Hoyo C, Cook MB, Kamangar F, et al., Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012; 41: 1706-18.
15. Cook MB, Corley DA, Murray LJ, et al., Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: A pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One 2014; 9: E103508.
16. Lubin JH, Cook MB, Pandeya N, et al., The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol 2012; 36: 306-16.
17. Liao LM, Vaughan TL, Corley DA, et al., Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology 2012; 142: 442-52.e5; quiz e22-3.
18. Freedman ND, Murray LJ, Kamangar F, et al., Alcohol intake and risk of oesophageal adenocarcinoma: A pooled analysis from the BEACON Consortium. Gut 2011; 60: 1029-37.
19. Chow WH, Blot WJ, Vaughan TL, et al., Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150-5.
20. Chak A, Falk G, Grady WM, et al., Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol 2009; 104: 1913-21.
21. Anderson LA, Watson RG, Murphy SJ, et al., Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study. World J Gastroenterol 2007; 13: 1585-94.
22. Brown LM, Silverman DT, Pottern LM, et al., Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: Alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994; 5: 333-40.
23. Chen H, Ward MH, Graubard BI, et al., Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 2002; 75: 137-44.
24. Cheng KK, Sharp L, McKinney PA, et al., A case-control study of oesophageal adenocarcinoma in women: A preventable disease. Br J Cancer 2000; 83: 127-32.
25. Corley DA, Kubo A, Zhao W., Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008; 17: 352-8.
26. Freedman ND, Abnet CC, Leitzmann MF, et al., A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165: 1424-33.
27. Gammon MD, Schoenberg JB, Ahsan H, et al., Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 1277-84.
28. Lagergren J, Bergstrom R, Lindgren A, et al., The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000; 85: 340-6.
29. Vaughan TL, Davis S, Kristal A, et al., Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92.
30. Veugelers PJ, Porter GA, Guernsey DL, et al., Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006; 19: 321-8.
31. Ward MH, Sinha R, Heineman EF, et al., Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997; 71: 14-9.
32. Whiteman DC, Sadeghi S, Pandeya N, et al., Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173-80.
33. Wu AH, Wan P, Bernstein L., A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12: 721-32.
34. Cook MB, Kamangar F, Whiteman DC, et al., Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: A pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010; 102: 1344-53.
35. Reid BJ, Li X, Galipeau PC, et al., Barrett's oesophagus and oesophageal adenocarcinoma: Time for a new synthesis. Nat Rev Cancer 2010; 10: 87-101.
36. Abrams JA, Sharaiha RZ, Gonsalves L, et al., Dating the rise of esophageal adenocarcinoma: Analysis of Connecticut Tumor Registry data, 1940-2007. Cancer Epidemiol Biomarkers Prev 2011; 20: 183-6.
37. Kubo A, Cook MB, Shaheen NJ, et al., Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: A pooled analysis from the international BEACON consortium. Gut 2013; 62: 1684-91.
38. Hoyo C, Cook MB, Kamangar F, et al., Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012; 41: 1706-18.
39. Kong CY, Nattinger KJ, Hayeck TJ, et al., The impact of obesity on the rise in esophageal adenocarcinoma incidence: Estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev 2011; 20: 2450-6.
40. Ryan AM, Duong M, Healy L, et al., Obesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets. Cancer Epidemiol 2011; 35: 309-19.
41. Drahos J, Ricker W, Parsons R, et al., Metabolic syndrome increases risk of barrett esophagus in the absence of gastroesophageal reflux: An analysis of SEER-Medicare data. J Clin Gastroenterol 2015; 49: 282-8.
42. Chiu HY, Chen CW, Lin HT, et al., Study of gastric fluid induced cytokine and chemokine expression in airway smooth muscle cells and airway remodeling. Cytokine 2011; 56: 726-31.
43. O'Riordan JM, Abdel-latif MM, Ravi N, et al., Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005; 100: 1257-64.
44. Souza RF, Huo X, Mittal V, et al., Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009; 137: 1776-84.
45. Hanahan D, Weinberg RA., Hallmarks of cancer: The next generation. Cell 2011; 144: 646-74.
46. Kavanagh ME, O'Sullivan KE, O'Hanlon C, et al., The esophagitis to adenocarcinoma sequence; the role of inflammation. Cancer Lett 2014; 345: 182-9.
47. Dhillon PK, Farrow DC, Vaughan TL, et al., Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001; 93: 148-52.
48. Ji J, Hemminki K., Familial risk for esophageal cancer: An updated epidemiologic study from Sweden. Clin Gastroenterol Hepatol 2006; 4: 840-5.
49. Jiang X, Tseng CC, Bernstein L, et al., Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: A case-control study. BMC Cancer 2014; 14: 60.
50. Zhang ZF, Kurtz RC, Sun M, et al., Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996; 5: 761-8.
51. Bredenoord AJ, Weusten BL, Curvers WL, et al., Determinants of perception of heartburn and regurgitation. Gut 2006; 55: 313-18.